Of Thoughts and Language
The push for healthcare equity has profoundly changed the way we view healthcare, including how we speak in medical settings....
Financial Toxicity
Mr. S did everything he could to beat his cancer. In the end, it was not the cancer but the...
The Hospital’s Eyes
Paul the hospital janitor may appear lowly in the eyes of those who pass him by. However, he keenly observes...
An Evening’s Kiss
Sarah and Evan are on a date and decide to go for a walk. But to find true love, they...
Irony of Measuring Physician Burnout
Physician burnout is finally receiving the recognition it deserves. And in our world of quantitative medicine, we seek to measure...
Peer Reviewed by Social Media
Clinical research and social media have a bizarre relationship, a complex interdependence that we have yet to fully understand. The...
A Matter of Good Faith
The Supreme Court has agreed to clarify the question of good faith as it pertains to physician prescribing behavior. In...
Pandemic Policy Reversals were Predicted
The pandemic has been characterized by poorly conceived policies and their inevitable reversals - with subsequent public outrage. However, these...
Medical Data vs. Medical Necessity
This far into the pandemic, most have become aware of data's influence in deriving policy. But using data to make...
American Individualism, Healthcare Externalities
Individualism has been the defining feature of American culture. Yet, as we enter into a post-pandemic world in which healthcare...
Journalists Decide When COVID-19 Ends
The public's fascination with COVID-19 began with the attention journalists gave to it. But now that public interest in the...
Direct to Consumer Chronic Care Management
Trends in healthcare market forces have predicted new startup business models, including the early success of direct to consumer models...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more